Introduction {#s01}
============

Antigen receptor diversity enables lymphocytes to initiate effective immune responses against a virtually limitless array of pathogens. The diversity in the primary antigen receptor repertoire is achieved by V(D)J recombination, a site-specific reaction catalyzed by a heterotetrameric protein complex encoded by the recombination-activating genes *RAG1* and *RAG2* ([@bib26]; [@bib55]). The RAG recombinase (RAG1/2) joins randomly selected variable, diversity, and joining (V, D, and J) gene segments to assemble a V(D)J exon that encodes the variable region of antibodies and T cell receptors ([@bib56]; [@bib57]). RAG1/2 does so in part by recognizing and cleaving conserved recombination signal sequences (RSSs) that flank each V, D, and J gene segment. RAG1 is the principal DNA binding and cleavage component of the recombinase. RAG2 is an essential cofactor and consists of a core portion (RAG2^core^) minimally required for its activity and a C-terminal region important for efficiency, fidelity, and ordering of V(D)J rearrangements ([@bib59]; [@bib32]; [@bib2]; [@bib60]; [@bib12]).

RSSs are comprised of a conserved palindromic heptamer (consensus: 5′-CACAGTG-3′) that is required for DNA cleavage, a degenerate spacer of 12 or 23 bp, and a less-conserved A-rich nonamer (consensus: 5′-ACAAAAACC-3′) that is important for RAG1/2 binding ([@bib56]; [@bib57]). RSSs with 12- or 23-bp spacers are termed 12RSSs and 23RSSs, respectively. During V(D)J recombination, RAG1/2 first binds to a single 12- or 23RSS (signal complex) and then captures a "complementary" 23- or 12RSS (paired complex) according to the "12/23 rule." Upon synapsis, the recombinase introduces DNA double-strand breaks between coding sequences and flanking RSSs by making a single-strand nick that is used to catalyze a transesterification that produces a hairpin-sealed coding end and a blunt-cut signal end. After cleavage, RAG1/2 remains associated with paired coding and signal ends in a post-cleavage complex, thereby scaffolding their repair by nonhomologous end joining (NHEJ). Coding ends are fused to produce V(D)J-coding exons, and ligation of signal ends generates noncoding signal joints. Depending on the orientation of paired RSSs, RAG1/2 catalyzes either inversional (head-to-tail RSSs) or deletional (convergent RSSs) recombination. During inversional recombination, signal joints remain in the genome, whereas they are excised as episomal signal joints during deletional recombination ([@bib20]).

In addition to its essential role in adaptive immunity, RAG1/2 has been implicated in the genesis of chromosome translocations and deletions associated with lymphoid malignancy ([@bib54]; [@bib33]). Mice deficient for ataxia-telangiectasia mutated kinase (ATM) or both the tumor suppressor protein p53 and components of the NHEJ machinery develop RAG1/2-dependent chromosome translocations associated with pro--B cell lymphomas ([@bib43]; [@bib3]). In humans, RAG1/2 is implicated in the genesis of follicular lymphoma (FL), mantle cell lymphoma, and acute lymphoblastic leukemia (ALL), all of which carry genome aberrations in the proximity of RSSs in antigen receptor genes or nonphysiological cryptic RSSs (cRSSs) with conserved heptamer motifs ([@bib28]; [@bib43]; [@bib3]). Predicted cRSSs are broadly distributed throughout the genome, and so are RAG1/2 binding sites, as assayed by chromatin immunoprecipitation ([@bib31]; [@bib24]; [@bib38]; [@bib62]). Consistent with the idea that RAG1/2 can induce DNA damage at cRSSs, it causes chromosomal deletions, and in the context of ATM deficiency also translocations, between engineered RSSs and genomic cRSSs in primary pro--B cells and pro--B cell lines ([@bib23]). The reported off-target mechanism involves directional, linear tracking of RAG1/2 within chromosomal loop domains to locate RSS/cRSS pairs ([@bib23]).

Biochemical experiments as well as episomal assays in cell lines and yeast suggest that RAG1/2 can mediate DNA transposition by inserting RSS-containing donor sequences into target DNA ([@bib1]; [@bib21]; [@bib29]; [@bib42]; [@bib9]; [@bib19]; [@bib64]; [@bib8]; [@bib47]; [@bib50]). Experiments with reporter cell lines indicate that RAG1/2 can also catalyze trans-V(D)J recombination, during which episomal signal joints are reinserted at an endogenous RSS or cRSS ([@bib50]). Nevertheless, only a few RAG1/2-mediated genomic insertions have been documented in vivo ([@bib39]; [@bib13]; [@bib65]). Moreover, RAG1/2-mediated DNA insertions contributing to cancer display characteristics that are not compatible with either DNA transposition or trans-V(D)J recombination ([@bib41]). Hence, how RAG1/2 causes genomic DNA insertions is still largely unknown.

Here we use translocation capture sequencing (TC-Seq) and insertion capture sequencing (IC-Seq) to analyze chromosomal rearrangements in primary murine developing B cells. We identify aberrant RAG1/2-dependent DNA deletions at immunoglobulin (*Ig*) genes, whose products are reinserted at DNA breaks generated by the I-SceI endonuclease on a heterologous chromosome. The existence of similar insertions in human cancer indicates that RAG1/2 also mobilizes genomic DNA into independent physiological breaks. Thus, our findings reveal a novel pathway through which RAG1/2 causes DNA insertions independent of DNA transposition and trans-V(D)J recombination. Importantly, this pathway has the potential to destabilize the lymphocyte genome by causing aberrant signal-end, hybrid-end, and coding-end insertions at RAG1/2-independent DNA breaks and shares features with reported oncogenic DNA insertions.

Results {#s02}
=======

Chromosomal rearrangements in pro--B cells {#s03}
------------------------------------------

To examine RAG1/2-induced chromosomal rearrangements in pro--B cells, we adapted a previously described next-generation TC-Seq method ([@bib27]; [@bib45]). TC-Seq captures genome-wide chromosomal rearrangements to a unique DNA double-strand break created by the I-SceI endonuclease. DNA rearrangements between the I-SceI break and the genome are amplified by PCR, deep-sequenced, and analyzed computationally. We prepared TC-Seq libraries from cell cultures of primary murine pro--B cells deficient for RAG2 and harboring I-SceI sites at c-*myc* (*RAG2^−/−^Myc^I/I^*) that were infected with retroviruses expressing either I-SceI alone (RAG2^−/−^ TC-Seq libraries) or I-SceI together with murine RAG2^core^ (RAG2^core^ TC-Seq libraries; [Fig. 1 A](#fig1){ref-type="fig"} and Fig. S1 A; also see Materials and methods). RAG2^core^ was used because it promotes aberrant V(D)J recombination and causes genomic instability at T cell receptor (*TCR*) loci in thymocytes ([@bib59]; [@bib60]; [@bib12]; [@bib14]). Moreover, mice expressing RAG2^core^ and deficient for either p53 alone or in combination with XRCC4-like factor develop thymic or pro--B cell lymphomas, respectively, with translocations involving antigen receptor genes ([@bib14]; [@bib40]; [@bib30]).

![**Landscape of chromosomal rearrangements in primary pro--B cells by TC-Seq.** (A) Detection of RAG1/2^core^-induced chromosomal rearrangements by TC-Seq. Primary *RAG2^−/−^Myc^I/I^* pro--B cells were infected ex vivo with retroviruses that express either I-SceI alone (RAG2^−/−^ TC-Seq libraries) or I-SceI together with murine RAG2^core^ (RAG2^core^ TC-Seq libraries) by using a "self-cleaving" P2A peptide. DNA breaks, such as those induced by RAG1/2^core^ at *Igκ* on chromosome 6 (red lightning), rearrange to the I-SceI break at c-*myc* on chromosome 15 (black lightning) and are subsequently amplified by PCR, deep-sequenced, and analyzed computationally. RAG2^core^ and RAG2^−/−^ TC-Seq libraries were prepared in independent duplicates from infected pro--B cells of 180 mice. (B) Chromosomal distribution of rearrangements. Events were normalized per megabase to account for different chromosome sizes. (C) Profile of rearrangements around the I-SceI site in 5-kb intervals. Dashed lines indicate the ±50-kb region excluded from the analysis for D--F because of saturation. (D) Proportion of genic rearrangements. (E) Frequency of rearrangements derived from differentially transcribed genes compared with a random model (dashed line). Asterisks indicate values significantly different from random (P \< 0.01, binominal test). (F) Observed number of rearrangements (o, triangle) originating from ERFSs compared with the random Monte Carlo simulation (s, Tukey boxplot). Asterisks indicate significant enrichment (P \< 0.0001, binominal test). For D--F, events from the saturated I-SceI region, cryptic I-SceI sites, and other portions of the genome were excluded (see Materials and methods). Data analysis was performed with pooled RAG2^core^ and RAG2^−/−^ TC-Seq libraries (two independent experiments each). See also Fig. S1 (A and B).](JEM_20161638_Fig1){#fig1}

In agreement with previous TC-Seq studies in other cell types, chromosomal rearrangements in pro--B cells were especially abundant near the I-SceI cleavage site on chromosome 15 ([Fig. 1, B and C](#fig1){ref-type="fig"}; [@bib27]; [@bib66]; [@bib53]). Moreover, rearrangements were enriched at genic regions, highly transcribed genes, and early replication fragile sites (ERFSs), which define regions particularly susceptible to DNA damage during early replication ([Fig. 1, D--F](#fig1){ref-type="fig"}; [@bib5]).

DNA damage at physiological RSSs and cRSSs {#s04}
------------------------------------------

To identify the DNA damage caused by RAG1/2^core^, we compared chromosomal rearrangements in RAG2^core^ and RAG2^−/−^ TC-Seq libraries. In brief, genomic hotspots of rearrangement were identified, and those unique to RAG1/2^core^ were analyzed for the occurrence of breakpoint clusters (see Materials and methods). Overall, 33 RAG1/2^core^-dependent rearrangement breakpoint clusters were detected throughout the genome (Table S1).

In agreement with previous studies, we observed limited recombination of the *Igh* locus by RAG1/2^core^ and consequently detected only few disperse breakpoints at Vh, Dh, and Jh gene segments (Fig. S1 B and not depicted; [@bib32]; [@bib2]). In contrast, 24 RAG1/2^core^-dependent breakpoint clusters were identified at *Igκ* ([Fig. 2 A](#fig2){ref-type="fig"} and Table S1). Each functional Jκ segment (Jκ1, Jκ2, Jκ4, and Jκ5) had a single cluster at its 23RSS cleavage site ([Fig. 2 B](#fig2){ref-type="fig"}). Surprisingly, DNA at these clusters recombined with the I-SceI break in a biased manner. Although in principle both DNA ends of a RAG1/2^core^-induced break would have an equal probability of joining to the cleaved I-SceI site, most rearrangements occurred with only one of the two ends for any RSS. For example, rearrangements between the I-SceI break and RAG1/2^core^ breaks at Jκ1 exclusively involved the coding end ([Fig. 2 B](#fig2){ref-type="fig"}, rearrangements in gray), whereas those at the neighboring Jκ2 predominantly (86%) contained the signal end ([Fig. 2 B](#fig2){ref-type="fig"}, rearrangements in green). Moreover, rearrangements at Jκ1 did not extended beyond the 23RSS cleavage site of Jκ2, and vice versa. A similar phenomenon was observed for Jκ4/Jκ5 ([Fig. 2 B](#fig2){ref-type="fig"}).

![**Rearrangements between I-SceI and RAG1/2^core^-induced DNA breaks at *Igκ*.** (A) Overview of rearrangement breakpoints at the *Igκ* locus on chromosome 6. Histogram of the number of breakpoints in the presence or absence of RAG2^core^ (red and black, respectively) in 10-kb intervals. RAG1/2^core^-dependent rearrangement breakpoint clusters are indicated by red triangles and labeled with the corresponding Jκ or Vκ gene segment. Asterisks mark breakpoint clusters with biased rearrangements (see B--D). Chromosome coordinates and scale bar are indicated on top. (B--D) Examples of RAG1/2^core^-dependent breakpoint clusters at Jκs and Vκs. On top is a diagram of the region, with gray boxes representing *Ig* segments, triangles indicating 12/23RSSs (green) or cRSSs (purple), and red bars indicating the breakpoint clusters. In the middle is a histogram showing the number and position of breakpoints (Bp, red). At the bottom, each horizontal line indicates a unique rearrangement (Rx), with its breakpoint represented by the vertical line and its sheared end (which determines the uniqueness of the event) shown by the box. Color coding indicates whether rearrangements contain RSSs/cRSSs (green/purple, signal ends) or not (gray, coding ends). Rearrangements in black are undefined. Chromosome coordinates and scale bar are indicated on top. Data analysis was performed with pooled RAG2^core^ and RAG2^−/−^ TC-Seq libraries (two independent experiments each). See also Fig. S2 (A--C) and Tables S1 and S2.](JEM_20161638_Fig2){#fig2}

In addition to Jκs, breakpoint clusters were also found at 15 Vκ gene segments. Strikingly, although 10 of these had a single cluster at their physiological 12RSS cleavage sites, the other 5 (Vκ3-1, Vκ10-94, Vκ10-95, Vκ10-96, and Vκ1-110) revealed an additional cluster at a nearby cRSS ([Fig. 2 A](#fig2){ref-type="fig"} and Table S1). Overall, the heptamer sequences of these cRSSs were similar to the physiological consensus and to those identified in previous studies (Fig. S2 A; [@bib23]). However, none of the cRSSs were detectable by computational tools because of their low RSS information content (RIC) scores (Table S2; [@bib11]; [@bib38]). Similar to the biased recombination pattern observed at Jκs, Vκ rearrangements at neighboring 12RSS/cRSS clusters were biased for coding or signal ends and limited in length by both cleavage sites ([Fig. 2, C and D](#fig2){ref-type="fig"}).

The remaining breakpoint clusters (nine) mapped to off-target regions outside of *Ig* loci (Table S1). Off targets were preferentially in transcribed genes (six) but not enriched in histone H3 lysine-4 trimethylation (H3K4me3), an active chromatin mark (unpublished data). Off-target clusters occurred near cRSS motifs that were similar to those identified at Vκ segments and also undetectable by computational tools (Fig. S2, A--C; and Table S2).

We conclude that RAG1/2^core^ damages the B cell genome at physiological RSSs and cRSSs, and that some of the resulting DNA breaks at Jκs and Vκs recombine with the cleaved I-SceI site in a biased manner.

Aberrant deletions at *Igκ* {#s05}
---------------------------

The peculiar rearrangement pattern observed at Jκ and some of the Vκ clusters suggested that RAG1/2^core^ may mediate aberrant deletions by recombining neighboring RSSs and cRSSs at these sites. To examine this possibility, we searched for deletions by poison primer PCR (see Materials and methods; [@bib18]). Strikingly, aberrant deletions mediated by either RAG1/2^core^ or endogenous wild-type RAG1/2 were readily detected at Jκs, where the RSSs at Jκ1 and Jκ4 were joined to the neighboring Jκ2 and Jκ5 exons, respectively ([Fig. 3, A and B](#fig3){ref-type="fig"}). The resulting deletion junctions (hybrid joints) represent aberrant joining events because physiological recombination of head-to-tail RSSs induces inversions and only involves 12/23RSS pairs ([@bib20]). However, some of these joints could also originate from two sequential inversions involving nearby Vκs, similar to those observed between D segments at *TCRδ* in thymocytes and between engineered RSS/cRSS pairs in ATM-deficient pro--B cell lines ([@bib23]; [@bib70]). In addition to those at Jκs, deletions mediated by either RAG1/2^core^ or RAG1/2 wild type were also identified at Vκ3-1, where joining of the 12RSS to the nearby cRSS described above generated aberrant signal joints ([Fig. 3 C](#fig3){ref-type="fig"}). We conclude that both RAG1/2^core^ and RAG1/2 wild type cause aberrant genomic deletions at Jκ and Vκ segments.

![**Aberrant deletions at *Igκ* mediated by RAG1/2^core^ and RAG1/2 wild type.** (A--C) Deletions between neighboring RSSs or RSS/cRSS at Jκs and Vκs, respectively. (top) Diagram of the locus before and after deletion by RAG1/2^core^ or RAG1/2 wild type. The predicted size of the deletion is shown above. Gray boxes represent *Ig* segments, triangles indicate 12/23RSSs (green) or cRSSs (purple), red lightning points to RAG1/2 cleavage sites, and black arrows indicate the location of the internal primers used for the deletion PCR (see Materials and methods). (bottom) Ethidium bromide--stained agarose gel with deletion PCR amplicons from cultured RAG1/2^core^ (Co), RAG1/2 wild type (Wt), or RAG2^−/−^ (Control) bone marrow B cells and water control (0). Red arrows point to amplified deletion junctions. DNA ladder with fragment sizes in kilobases is shown alongside. Deletions were captured from 20,000 (A and B) or 40,000 (C) cells/well. Selected amplicons were extracted and confirmed by sequencing. The frequency of aberrant deletions was subsequently determined by dilutional PCR. For Co: 1 in 4,000 cells in A, 1 in 20,000 cells in B, and 1 in 600 cells in C; for Wt: 1 in 3,600 cells in A, 1 in 2,700 cells in B, and 1 in 39,300 cells in C. The frequency of deletions by RAG1/2^core^ was lower in the repeat experiment (see Materials and methods). All results were verified by at least two independent experiments.](JEM_20161638_Fig3){#fig3}

Excised *Igκ* fragments insert into I-SceI breaks {#s06}
-------------------------------------------------

Based on the colocalization of biased rearrangements and aberrant deletions, we hypothesized that Jκ/Vκ fragments might be aberrantly excised by RAG1/2^core^ and subsequently reintegrate at the I-SceI break ([Fig. 4 A](#fig4){ref-type="fig"}; see Discussion). To test this hypothesis, we searched TC-Seq libraries computationally for bona fide insertions, which would have been excluded from our initial bioinformatic analysis geared at identifying translocations. In brief, insertions at the I-SceI site are flanked by *Myc^I^* sequence on both ends, whereas translocations contain *Myc^I^* sequence only on one end ([Fig. 4 A](#fig4){ref-type="fig"}). Thus, all sequences with *Myc^I^* on both ends were examined for intervening DNA originating from elsewhere in the genome (see Materials and methods).

![**Landscape of insertions in primary pro--B cells by TC-Seq.** (A) Cartoon diagram comparing RAG1/2^core^-induced translocations and insertions. In a translocation (red), RAG1/2^core^ introduces a single DNA break (red lightning) that recombines with the cleaved I-SceI site at *Myc^I^* (black lightning) on chromosome 15. The resulting translocation contains *Myc^I^* only on one side. In an insertion (blue), RAG1/2^core^ causes tandem DNA breaks (blue lightning), thereby excising a DNA fragment that subsequently reintegrates into the cleaved I-SceI site. The resulting insertion is flanked by *Myc^I^* on both sides. (B) Origin of insertions by chromosome. Events were normalized per megabase to account for different chromosome sizes. (C) Profile of insertions near the I-SceI site in 5-kb intervals. Dashed lines indicate the ±20-kb region excluded from the analysis for D--F because of saturation. (D) Proportion of insertions from genic regions. (E) Frequency of insertions derived from differentially transcribed genes compared with a random model (dashed line). Asterisks indicate values significantly different from random (P \< 0.01, binominal test). (F) Observed number of insertions (o, triangle) originating from ERFSs compared with the random Monte Carlo simulation (s, Tukey boxplot). Asterisks indicate significant enrichment (P \< 0.0001, binominal test). For D--F, events from the saturated I-SceI region, cryptic I-SceI sites, and other portions of the genome were excluded (see Materials and methods). Data analysis was performed with pooled RAG2^core^ and RAG2^−/−^ TC-Seq libraries (two independent experiments each).](JEM_20161638_Fig4){#fig4}

We detected I-SceI insertions in both RAG2^core^ and RAG2^−/−^ TC-Seq libraries. Independent of RAG2^core^ expression, inserted DNA fragments originated predominantly from a ±20-kb region around the I-SceI cleavage site on chromosome 15, similar to the chromosomal rearrangements described above ([Fig. 1, B and C](#fig1){ref-type="fig"}; and [Fig. 4, B and C](#fig4){ref-type="fig"}). Overall, inserted DNA fragments ranged from 36 to 354 bp in RAG2^core^ and from 36 to 232 bp in RAG2^−/−^ cells (36 bp being the minimum detection limit; see Materials and methods). Moreover, genic regions acted as preferred donors for insertions, particularly in RAG2^core^-expressing cells ([Fig. 4 D](#fig4){ref-type="fig"}). In contrast, insertions originating from highly transcribed regions and ERFSs were significantly enriched only in the absence of RAG2^core^, indicating that its expression alters the insertion landscape ([Fig. 4, E and F](#fig4){ref-type="fig"}). Thus, we found more insertions from chromosome 6 in RAG2^core^ compared with RAG2^−/−^ cells (140 vs. 8 events; [Fig. 4 B](#fig4){ref-type="fig"}), and with RAG2^core^ nearly all of those (96%) originated from *Igκ*, whereas none derived from this locus in RAG2^−/−^ cells ([Fig. 5 A](#fig5){ref-type="fig"}). Overall, *Igκ* insertions represented nearly half (43%) of all insertions in RAG2^core^ cells and exclusively originated from regions flanked by RSSs and/or cRSSs ([Fig. 5, B--D](#fig5){ref-type="fig"}). Interestingly, donor regions included all of the *Igκ* gene segments displaying biased breakpoint clusters, suggesting that DNA insertions from these sites are responsible for the observed recombination pattern (see [Figs. 2](#fig2){ref-type="fig"} and [5](#fig5){ref-type="fig"} and Discussion).

![**Insertions of RAG1/2^core^-mobilized DNA into the I-SceI site.** (A) Overview of insertions originating from the *Igκ* locus on chromosome 6. Histogram of the number of insertions derived from each site in the presence or absence of RAG2^core^ (blue and black, respectively) in 10-kb intervals. RAG1/2^core^-dependent rearrangement breakpoint clusters at Jκs and Vκs (triangles, same as in [Fig. 2 A](#fig2){ref-type="fig"}) are color coded to indicate whether insertions from these sites are detected (blue) or not (red). Asterisks mark breakpoint clusters with biased rearrangements (see [Fig. 2 \[B--D\]](#fig2){ref-type="fig"}). No insertions from *Igκ* were detected in RAG2^−/−^ cells. Chromosome coordinates and scale bar are indicated on top. (B--D) Examples of insertions derived from RAG1/2^core^-dependent breakpoint clusters at Jκs and Vκs. On top is a diagram of the region, with gray boxes representing *Ig* segments, triangles indicating 12/23RSSs (green) or cRSSs (purple), and red bars indicating the breakpoint clusters (same as in [Fig. 2 \[B--D\]](#fig2){ref-type="fig"}). In the middle is a histogram showing the number and position of breakpoints (Bp, red). At the bottom, each horizontal line indicates a unique insertion (Ins), with its breakpoints represented by the vertical lines at the ends. Arrows represent insertions for which only one of the two breakpoints could be identified. Chromosome coordinates and scale bar are indicated on top. Data analysis was performed with pooled RAG2^core^ and RAG2^−/−^ TC-Seq libraries (two independent experiments each). See also Table S3.](JEM_20161638_Fig5){#fig5}

For 67% of *Igκ* insertions, we obtained sequence information on both junctions, providing insight into the original deletion events (Table S3). Overall, *Igκ* insertions originated from DNA excision between pairs of divergent, convergent, or head-to-tail RSSs, leading to insertions flanked by coding ends (coding-end insertions, 77), signal ends (signal-end insertions, 8), or both (hybrid-end insertions, 6), respectively ([Fig. 5, B--D](#fig5){ref-type="fig"}; and Table S3). Most deletions (87 out of 91) occurred between RSS/cRSS pairs, three resulted from excisions between two cRSSs, and one derived from a deletion between two 23RSSs. We conclude that RAG1/2^core^ generates aberrant *Ig* fragments that are mobile and can be reinserted into I-SceI breaks on a heterologous chromosome.

Insertion of *Igκ* fragments excised by wild-type RAG1/2 {#s07}
--------------------------------------------------------

As demonstrated by our deletion PCR assays, RAG1/2 can produce aberrant *Igκ* deletions analogous to RAG1/2^core^. Thus, mobilization and insertion of *Igκ* DNA could in principle also occur in wild-type B cells. To test this possibility, we developed a next-generation IC-Seq method that qualitatively documents chromosomal insertions at an I-SceI site under physiological conditions. We prepared IC-Seq libraries from primary bone marrow B cells expressing a tamoxifen-inducible I-SceI transgene and bearing I-SceI cleavage sites (*ROSA^erISCEI^Myc^I/I^Igh^I/I^* and *ROSA^erISCEI^Myc^I/I^Igh^I/I^AID^−/−^*; see Materials and methods; [@bib53]) that were treated ex vivo with tamoxifen to induce I-SceI breaks in the presence of wild-type RAG1/2. DNA insertions at the I-SceI site in c-*myc* were amplified by PCR, deep-sequenced, and analyzed computationally ([Fig. 6 A](#fig6){ref-type="fig"}; see Materials and methods).

![**Insertions at the I-SceI site induced by wild-type RAG1/2.** (A) Detection of chromosomal insertions by IC-Seq. Primary *ROSA^erISCEI^Myc^I/I^Igh^I/I^* (and *ROSA^erISCEI^Myc^I/I^Igh^I/I^AID^−/−^*, see Materials and methods) bone marrow B cells were treated ex vivo with tamoxifen to induce I-SceI breaks at c-*myc* on chromosome 15 (black lightning). Mobilized DNA fragments, such as those excised by endogenous RAG1/2 from *Igκ* on chromosome 6 (blue lightning), reinsert into the cleaved I-SceI site and are subsequently amplified by PCR, deep-sequenced, and analyzed computationally. Two RAG1/2 wild-type IC-Seq libraries were independently prepared from tamoxifen-treated bone marrow B cells of 12 mice. (B--D) Qualitative comparison of insertions obtained by TC-Seq (RAG1/2^core^) and IC-Seq (RAG1/2 wild type). On top is a diagram of the region, with gray boxes representing *Ig* segments and triangles indicating 12/23RSSs (green) or cRSSs (purple). Below, insertions detected by TC-Seq (Ins, same as in [Fig. 5 \[B--D\]](#fig5){ref-type="fig"}) and IC-Seq (IC). Each horizontal line indicates a unique insertion, with its breakpoints represented by the vertical lines at the ends. Arrows represent insertions for which only one of the two breakpoints could be identified. Chromosome coordinates and scale bar are indicated on top. Data analysis was performed with pooled IC-Seq libraries (two independent experiments). See also Table S3.](JEM_20161638_Fig6){#fig6}

Overall, we detected I-SceI insertions from seven different *Igκ* gene segments (Jκ1, Jκ2, Jκ4, Jκ5, Vκ1-110, Vκ3-1, and Vκ4-69), of which six were also involved in the aforementioned insertions mediated by RAG1/2^core^ (Table S3). Moreover, similar to RAG1/2^core^, *Igκ* insertions in the presence of RAG1/2 originated exclusively from donor regions flanked by RSSs/and or cRSSs and were comprised of coding-, signal-, and hybrid-end insertions ([Fig. 6, B--D](#fig6){ref-type="fig"}; and Table S3). We conclude that DNA insertions from *Igκ* are not limited to RAG1/2^core^ but also occur during physiological V(D)J recombination by wild-type RAG1/2.

Insertion of *IG* and *TCR* fragments at physiological DNA breaks {#s08}
-----------------------------------------------------------------

To determine whether RAG1/2 causes insertions at physiological DNA breaks in vivo, we searched published whole-genome sequences from ALL and FL patients for insertions deriving from *IG* and *TCR* loci (see Materials and methods). Overall, 5 out of 34 patients displayed genomic insertions of *IG* or *TCR* fragments at low frequency (Table S4). All insertions contained at least one RSS or cRSS motif and integrated near repetitive regions ([Fig. 7 A](#fig7){ref-type="fig"} and Fig. S3). Interestingly, DNA flanking one of the inserts was inverted to form a putative cRSS/cRSS signal joint, and in another case, a *TCR* fragment inserted at a translocation junction ([Fig. 7, A and B](#fig7){ref-type="fig"}). We conclude that RAG1/2 has the potential to destabilize the lymphocyte genome by mobilizing DNA that then reinserts at RAG1/2-independent, physiological DNA breaks in vivo.

![**RAG1/2-induced insertions at physiological DNA breaks in vivo.** (A) Diagram representing *IG*/*TCR* insertions detected in human cancer. From top to bottom: hypodiploid ALL (first), early T cell precursor ALL (second and third), and FL (fourth and fifth). Boxes indicate *IG*/*TCR* segments (gray) or repeat regions (black), and triangles represent 12/23RSSs (green) or cRSSs (purple). Inserted gene segments and RSSs/cRSSs are labeled with their corresponding *IG*/*TCR* segment of origin. Unresolved junctions are indicated by dashed lines/triangles. The insertion detected in hypodiploid ALL (top) is flanked by an upstream inversion (red arrow), forming a putative cRSS/cRSS signal joint. One of the insertions in FL (bottom) occurred at a translocation junction. Whole-genome sequences from 34 cancer patients were analyzed. (B) Diagram illustrating a putative RAG1/2-mediated DNA inversion caused by the insertion of a cRSS. Boxes represent *IG* segments (gray) or repeat regions (black), triangles indicate cRSSs (purple), and lightning indicates DNA cleavage induced by RAG1/2 (red) or unknown factors (black). From top to bottom: first, DNA is damaged at a simple CA-repeat region within *LINC00907* on chromosome 18. Second, the locus is opened at the break. Third, RAG1/2 excises a DNA fragment containing a cRSS from the *TCRα* locus on chromosome 14, which subsequently reinserts into the break (blue). Fourth, RAG1/2 cleaves and inverts DNA between the cRSS in the insert and a cRSS near the insertion site (red arrow). Finally, the DNA inversion generates a putative cRSS/cRSS signal joint as observed in A (top). See also Fig. S3 and Table S4.](JEM_20161638_Fig7){#fig7}

Discussion {#s09}
==========

RAG1/2 damages the pro--B cell genome at physiological RSSs and cRSSs {#s10}
---------------------------------------------------------------------

We used TC-Seq to examine chromosomal rearrangements in the pro--B cell genome and identified 33 RAG1/2^core^-dependent breakpoint clusters, of which 19 occurred at physiological RSS cleavage sites. Consistent with this finding, a previous study in ATM-deficient pro--B cell lines detected chromosomal rearrangements between I-SceI breaks at c-*myc* and RAG1/2-induced breaks at antigen receptor loci including *Igκ* ([@bib69]). Interestingly, off-target clusters at cRSSs were not detected in those experiments. In contrast, 14 of the 33 RAG1/2^core^-dependent breakpoint clusters identified herein were located near cRSS motifs at Vκs and off-target regions outside *Ig* loci. Off targets were not enriched in H3K4me3, an active chromatin mark that has been shown to colocalize with RAG1/2 binding and cleavage in developing B cells ([@bib24]; [@bib23]; [@bib62]; unpublished data). Its absence might result from the fact that RAG2^core^ lacks the C-terminal plant homeodomain, which normally mediates RAG1/2 binding to H3K4me3 ([@bib67]; [@bib34]; [@bib36]; [@bib49]).

Our results demonstrate that RAG1/2^core^-mediated cleavage of cRSSs enables chromosomal rearrangements by producing cleaved ends that can recombine with RAG1/2-independent DNA breaks. Moreover, our data confirms that neighboring RSSs and cRSSs are substrates for aberrant genomic deletions, in agreement with previous studies using engineered RSSs ([@bib35]; [@bib23]). We speculate that the cRSSs at Vκs identified herein might also serve as beneficial substrates for secondary V-J rearrangements during V-gene replacement, similar to those described at Vhs ([@bib48]).

Aberrantly excised *Igκ* DNA reinserts at I-SceI breaks {#s11}
-------------------------------------------------------

We hypothesized that some of the observed rearrangements resembling translocations may actually represent insertions of deleted DNA into the I-SceI break. Because DNA is sonicated during preparation of TC-Seq libraries, a fraction of insertions would be randomly truncated and appear as translocations in the analysis (see comparison between translocation and insertion in [Fig. 4 A](#fig4){ref-type="fig"}). In agreement with this prediction, we identified bona fide insertions originating from all RAG1/2^core^ breakpoint clusters with biased rearrangements. Furthermore, by using a novel next-generation sequencing method (IC-Seq), we confirmed *Igκ* insertions at I-SceI breaks in the presence of wild-type RAG1/2. *Igκ* insertions mediated by RAG1/2^core^ and RAG1/2 wild type were similar in that they both originated from donor regions with RSSs/cRSSs and were comprised of all three insertion species (signal-end, coding-end, and hybrid-end).

Overall, insertions detected by both TC-Seq and IC-Seq were short (354 bp or shorter). The absence of larger insertions is likely caused by technical limitations. During TC-Seq, which was originally designed to detect chromosomal translocations, the size of insertions is mainly limited by the sonication of genomic DNA (see Materials and methods). We therefore expect long insertions to be truncated and appear as "translocations" in the computational analysis. In this regard, some of the apparent translocations at Vκs and Jκs could in principle result from the insertion of large physiological excision fragments (tens to hundreds of kilobases). Moreover, because even short insertions can be truncated, it is possible that TC-Seq considerably underestimates the actual frequency of insertions. During IC-Seq, which omits DNA sonication, the major factor limiting the detection of large insertions is PCR amplification. DNA templates with large insertions are likely outcompeted by those with small or no insertions. Finally, both TC-Seq and IC-Seq use high-throughput sequencing (see Materials and methods), which is inefficient for DNA fragments \>1.5 kb.

*Igκ* insertions at I-SceI breaks are not mediated by DNA transposition or trans-V(D)J recombination {#s12}
----------------------------------------------------------------------------------------------------

We observed three distinct insertion species from *Igκ*: those flanked by RSS/cRSS pairs (signal-end insertions), those lacking RSSs altogether (coding-end insertions), and those bearing only one RSS or cRSS (hybrid-end insertions).

Signal-end insertions derive from DNA deletion between convergent RSSs, which are normally joined to form episomal signal joints. There is some in vivo evidence that RAG1/2 can induce genomic insertions by recleaving and subsequently reintegrating episomal signal joints through either trans-V(D)J recombination or DNA transposition ([@bib39]; [@bib13]; [@bib65]). However, the observed signal-end insertions are not compatible with these two pathways because they occur at RAG1/2-independent DNA breaks generated by I-SceI. In contrast, during trans-V(D)J recombination, it is RAG1/2 that cleaves the RSS/cRSS at the insertion site, and in DNA transposition, RAG1/2 is responsible for catalyzing the nucleophilic attack required for insertion. Thus, the RAG1/2-induced signal-end insertions observed in our study are mediated by a pathway distinct from these previously described mechanisms.

Coding-end insertions do not fit previously proposed RAG1/2 insertion mechanisms either because both trans-V(D)J recombination and DNA transposition require RSS-containing donor fragments ([@bib1]; [@bib21]; [@bib13]; [@bib65]). Coding-end insertions originate from DNA deletions between divergent RSSs, whose products are predicted to circularize into episomal coding joints. Because these cannot be recleaved by RAG1/2, coding-end insertions likely originate from noncircularized, linear deletion products.

Hybrid-end insertions derive from deletions between head-to-tail RSSs. In principle, such deletions produce episomal hybrid joints that contain a single RSS or cRSS. Although in vitro assays have shown that RAG1/2 can induce breaks at single RSSs, the extent to which this occurs in vivo is unclear ([@bib37]; [@bib17]; [@bib68]; [@bib48]). Hence, similar to coding-end insertions, those with hybrid ends likely derive from linear deletion products.

Although *Igκ* insertions originate from distinct types of RAG1/2 deletions, we propose a model in which they all share a common intermediate: excised linear DNA fragments that escaped from the post-cleavage complex before end joining ([Fig. 8](#fig8){ref-type="fig"}). This model agrees with biochemical experiments and studies with reporter cell lines showing that cleaved ends can prematurely escape the post-cleavage complex upon destabilization by RAG2^core^, nonconsensus RSS heptamers, or absence of the DNA damage response kinase ATM ([@bib6]; [@bib4]; [@bib14]; [@bib10]). Our data support this model in two ways. First, the occurrence of coding- and hybrid-end insertions speaks against DNA circularization and points to the existence of stable, linear DNA deletion products. Second, because DNA integration is independent of RAG1/2, neither donor fragments nor insertion sites require RSSs/cRSSs for the insertion process. In agreement with our findings, previous studies in reporter cell lines detected a few insertions of RSS-flanked donor substrates that were not mediated by DNA transposition or by trans-V(D)J recombination ([@bib8]; [@bib50]). Similarly, a study in primary T cells reported a few cases in which the insertion of a specific RSS-flanked *TCRβ* fragment occurred independently of both pathways ([@bib13]). We conclude that RAG1/2 likely mobilizes linear deletion products, which are stable and have the capacity to reinsert back into the genome at independently generated DNA breaks on heterologous chromosomes. Thus, our findings reveal a novel RAG1/2-mediated insertion pathway distinct from DNA transposition and trans-V(D)J recombination.

![**RAG1/2 mobilizes DNA from antibody gene segments into RAG1/2-independent DNA breaks.** (A--C) Cartoon diagram to illustrate the pathways leading to insertion of RAG1/2-mobilized DNA into I-SceI breaks. Aberrant RAG1/2-mediated DNA excision at Vκ1-110 (A), Vκ3-1 (B), and Jκ1/2 (C) generates signal-end, coding-end, and hybrid-end insertions, respectively. Boxes represent *Ig* segments (gray) or *Myc^I^* (black), triangles indicate RSSs (green) or cRSSs (purple), red lightning points to RAG1/2 cleavage sites, and brown ellipses represent the post-cleavage complex. From top to bottom: first, RAG1/2 induces DNA breaks at paired RSSs/cRSSs. Second, DNA is aberrantly excised, and cleaved ends remain bound to the post-cleavage complex to support their repair by the NHEJ machinery. Third, excised DNA is either circularized and released from the post-cleavage complex as episomal joint (right arrow) or it escapes before end joining as linear fragment (left arrow). For signal-end insertions (A), linear DNA fragments might also originate from recleavage of episomal signal joints by RAG1/2 (dashed arrow). For coding-end and hybrid-end insertions (B and C), recleavage of episomal joints is unlikely because of the absence of paired RSSs (crossed arrows). Finally, mobilized linear DNA fragments reinsert into the genome at the I-SceI break.](JEM_20161638_Fig8){#fig8}

Insertions derived from non-*Ig* loci {#s13}
-------------------------------------

Although RAG2^core^ expression significantly alters the landscape of chromosomal insertions at I-SceI breaks, the majority of events originates from outside the *Igκ* locus in both RAG2^core^ and RAG2^−/−^ pro--B cells (57% and 100% of total, respectively). Those insertions possibly derive from regions prone to genomic instability caused by DNA transcription, replication, or other sources of DNA damage. Consistent with this possibility, chromosomal insertions in RAG2^−/−^ cells preferentially originate from highly transcribed genes and ERFSs. Alternatively or in addition, non-*Igκ* insertions may represent "templated-sequence insertions" that derive from reverse-transcribed RNA ([@bib46]). Finally, we cannot exclude that some insertions originate from RAG1/2-mediated deletions at off-target sites. In this context, it is intriguing that insertions of non-*Ig* DNA into antibody receptor genes were recently shown to contribute to antibody diversification ([@bib61]).

RAG1/2 causes insertions at independent, physiological DNA breaks {#s14}
-----------------------------------------------------------------

As demonstrated by our computational analysis of human cancers, RAG1/2-induced DNA insertions are not limited to I-SceI breaks but also occur at physiological DNA breaks in vivo. The low number of *IG*/*TCR* insertions detected in our tumor analysis is likely caused by limitations of currently available datasets as well as general limitations of whole-genome sequencing techniques. Many of the publicly available tumor datasets either do not have a sufficient coverage or are not sequenced using long enough reads (e.g., 100 bp and longer) to allow for robust detection of insertion junctions. Moreover, the preparation of genomic libraries generally involves DNA fragmentation, which inevitably truncates existing insertions, thereby causing them to appear as translocations in the computational analysis.

Nevertheless, the detection of RAG1/2-induced insertions is particularly important because they pose a threat to genomic stability in at least two ways. First, they provide functional RSS and/or cRSS substrates for secondary rearrangements. In fact, introducing a RSS outside of *Ig* loci has been shown to cause aberrant RAG1/2-mediated deletions and inversions ([@bib35]; [@bib23]). Consistent with this, one of the tumor-associated insertions was accompanied by the formation of a putative cRSS/cRSS signal joint, which likely originated from a secondary RAG1/2-mediated DNA inversion between the cRSS in the insert and a nearby cRSS. These and other downstream recombinations (e.g., deletions and translocations) might also render RAG1/2-induced insertions especially difficult to detect. Second, although none of the insertions in the patients we analyzed are cancer drivers, the oncogenic insertion of an excised *TCR* fragment was recently described ([@bib41]). In the reported T-ALL patient, a DNA fragment flanked by two RSSs was excised from the *TCRβ* locus and reinserted upstream of the *TAL1* oncogene, causing its activation. Notably, the *TCRβ* fragment inserted at a RAG1/2-independent DNA break, analogous to the insertions detected in our study. Furthermore, the oncogenic insertion of an *IGH* fragment was described in a patient with diffuse large B cell lymphoma ([@bib7]). In the reported patient, a rearranged DJ fragment inserted into a translocation junction involving the *BCL6* oncogene led to the expression of an aberrant *BCL6-IGH* fusion transcript. Similarly, we detected an inserted *TCR* fragment at a translocation junction in our cancer analysis. Thus, RAG1/2 has the capacity to destabilize the lymphocyte genome by producing cancer-associated DNA insertions.

Materials and methods {#s15}
=====================

Mice {#s16}
----

Mutant mice used in this study include *RAG2^−/−^Myc^I/I^* (B6(Cg)-*Rag2^tm1.1Cgn^*/J (The Jackson Laboratory; [@bib52]), *ROSA^erISCEI^Myc^I/I^Igh^I/I^*, and *ROSA^erISCEI^Myc^I/I^Igh^I/I^AID^−/−^* ([@bib53]). All mice were in a C57BL/6 background or backcrossed to it for at least 10 generations. All experiments were performed in agreement with protocols approved by the Rockefeller University Institutional Animal Care and Use Committee.

Retroviruses {#s17}
------------

Murine RAG2 (RAG2^full^) and RAG2^core^ sequences were amplified from mouse genomic DNA using primers p2/p6 and p3/p6, respectively (Table S5). I-SceI was amplified from pMX-I-SceI-EGFP using primers p4/p5 (Table S5; [@bib52]). Overlap extension PCRs of the above products with primers p2/p4 and p3/p4 generated I-SceI-P2A-RAG2^full^ and I-SceI-P2A-RAG2^core^, respectively (Table S5). Finally, both constructs were cloned into pMX-EGFP to generate pMX-I-SceI-P2A-RAG2^full^-EGFP and pMX-I-SceI-P2A-RAG2^core^-EGFP, respectively.

Cell culture and infection for TC-Seq {#s18}
-------------------------------------

Pro--B cells were isolated from tibias, femurs, and humeri of *RAG2^−/−^Myc^I/I^* mice at 4--10 wk of age by immunomagnetic enrichment with anti-B220 MicroBeads (Miltenyi Biotec). Cells were cultured at 2.0 × 10^6^ cells/ml in the presence of IL-7 (5 ng/ml; Sigma-Aldrich) in complete RPMI (RPMI-1640 supplemented with [l]{.smallcaps}-glutamine \[Gibco\], sodium pyruvate \[Gibco\], antibiotic/antimycotic \[Gibco\], Hepes \[Gibco\], 55 µM β-mercaptoethanol \[Gibco\], and 10% fetal calf serum \[HyClone\]). IL-7 was replenished on day 2. On days 3 and 4, cell supernatants were replaced with retroviral supernatants resulting from cotransfection (Fugene-6; Roche) of BOSC23 cells with pCL-Eco and pMX-I-SceI-P2A-RAG2^core^-EGFP or pMX-I-SceI-EGFP plasmids 3 d before ([@bib52]). Spinoculation was at 1,111 *g* for 1.5 h in the presence of 2.5 µg/ml polybrene, 5 ng/ml IL-7, and 20 mM Hepes. After 6--8 h at 37°C, on day 3, retroviral supernatants were replaced with original supernatants, whereas on day 4, cells were collected for IL-7 washout and replating in fresh complete RPMI. Cells were harvested after 2.5 d of IL-7 depletion, sorted for EGFP expression with a FACSAria instrument (BD), pelleted, and snap-frozen on dry ice. Samples infected with pMX-I-SceI-P2A-RAG2^core^-EGFP are referred to as RAG2^core^, and those infected with pMX-I-SceI-EGFP are referred to as RAG2^−/−^.

Cell culture for IC-Seq {#s19}
-----------------------

Bone marrow B cells were isolated from tibias, femurs, and humeri of *ROSA^erISCEI^Myc^I/I^Igh^I/I^* and *ROSA^erISCEI^Myc^I/I^Igh^I/I^AID^−/−^* mice at 6--8.5 mo of age by immunomagnetic enrichment with anti-B220 MicroBeads (Miltenyi Biotec). Cells were pooled and cultured at 2.0 × 10^6^ cells/ml in the presence of IL-7 (5 or 10 ng/ml; Sigma-Aldrich) and tamoxifen (1 µM; Sigma-Aldrich) in complete RPMI. On day 1, cells were collected for IL-7 washout and replated in fresh complete RPMI with 1 µM tamoxifen. On day 2, cultures were harvested, and cell pellets were snap-frozen on dry ice.

TC-Seq library preparation {#s20}
--------------------------

TC-Seq libraries of RAG2^core^ and RAG2^−/−^ pro--B cells were prepared in duplicates from each of 50 million sorted cells, as previously described ([@bib27]; [@bib53]) with the exception that sonication of genomic DNA was performed with Covaris S220 (power 105, duty factor 5%, cycles 200, time 35 s, water level 12, temperature 7°C), yielding a core of DNA fragments between 500 and 850 bp. Each library was sequenced twice using Illumina MiSeq (300 cycles, paired-end).

IC-Seq library preparation {#s21}
--------------------------

IC-Seq libraries of bone marrow B cells were prepared in duplicates from 40 million and 60 million cultured cells. Genomic DNAs were extracted with phenol-chloroform after Proteinase K digestion, washed twice with 70% ethanol, and resuspended in TE buffer (Invitrogen). For the first PCR, 1 µg of DNA was amplified in each reaction with Phusion polymerase (New England Biolabs, Inc.) and the *Myc^I^* flanking primers p247/p251 with the following conditions: 98°C for 2 min; 35× (98°C for 10 s, 72°C for 1:30 min); and 72°C for 5 min (Table S5). Pooled PCR reactions were column purified (MACHEREY-NAGEL) and high molecular weight products (1,500--5,000 bp) were isolated by agarose gel electrophoresis. Extracted DNA was digested with I-SceI (New England Biolabs, Inc.) and column purified (MACHEREY-NAGEL). In the second PCR, 25 ng DNA were amplified in each reaction with Phusion polymerase (New England Biolabs, Inc.) and primers p274a/p275a, p274b/p275b, p274c/p275c, and p274d/p275d with the following conditions: 98°C for 2 min; 3× (98°C for 10 s, 65°C for 30 s, 72°C for 1 min); 32× (98°C for 10 s, 72°C for 1:15 min); and 72°C for 5 min (Table S5). PCR products were pooled, and high molecular weight amplicons (280--3,000 bp) were isolated by agarose gel electrophoresis. Extracted DNA was digested with I-SceI (New England Biolabs, Inc.) and column purified (MACHEREY-NAGEL). To add index adapters for sequencing, the PCR was similar to the second PCR but with primers pNextflex common/pNextflex index5 or pNextflex common/pNextflex index6 with the following conditions: 98°C for 2 min; 3× (98°C for 10 s, 67°C for 30 s, 72°C for 1 min); 32× (98°C for 10 s, 72°C for 1:15 min); and 72°C for 5 min (Table S5). PCR products were pooled, and high molecular weight amplicons (350--2,000 bp) were isolated by agarose gel electrophoresis. Extracted DNA was digested with I-SceI (New England Biolabs, Inc.) and column purified (MACHEREY-NAGEL), and high molecular weight products (300--2,000 bp) were isolated once more by agarose gel electrophoresis. Extracted DNA was sequenced twice using Illumina NextSeq (150 cycles, paired-end).

TC-Seq analysis {#s22}
---------------

Two independent libraries were sequenced twice, and the data were pooled for analysis using a novel pipeline to identify rearrangement and insertion breakpoints. First, sequencing reads were trimmed for high quality with seqtk (error rate threshold of 0.01; Broad Institute), and those with primer sequences from the first PCR or \<5 bp of *Myc^I^* after the nested primer sequence were discarded. Second, reads were mapped against *Myc^I^* with its repetitive regions masked using SMALT (v0.7.6; parameters: -c 11 -x -O; Sanger Institute). Paired reads that both aligned to *Myc^I^* at their 5′ end were analyzed in "insertion mode"; otherwise, they were processed in "rearrangement mode."

In rearrangement mode ([Figs. 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}), bases aligning to *Myc^I^* were clipped from either the beginning or the end of the reads, and the remaining sequences were mapped to the mouse genome (mm10) with SMALT (parameters: -O -r -1). Only alignments with at least 36 bp and a Phred score of 20 were accepted. Reads with the same sheared ends, which derive from sonication during library preparation, were merged into one event, and single reads were preserved. Rearrangements that did not yield breakpoints were discarded. Finally, reads that crossed the I-SceI site by \>3 bp were excluded.

In insertion mode ([Figs. 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}), bases aligning to *Myc^I^* were clipped from both ends of the reads, and the remaining sequences were mapped to the mouse genome (mm10) with SMALT (parameters: -O -r -1). Only alignments with at least 36 bp and a Phred score of 20 were accepted. Pairs with incorrect genomic orientation (+/+ and −/−) were excluded. The alignment of insertions yielded either both genomic breakpoints (double junctions) or only one (single junctions). Because of saturation at *Myc^I^*, events were merged if they possessed all of the following features: identical shears, genomic breakpoints within 5 bp, and same orientation. Events based on single reads were preserved. Finally, reads that crossed the I-SceI site by \>3 bp were excluded.

IC-Seq analysis {#s23}
---------------

Data from two independent libraries were pooled and analyzed similar to the "insertion mode" in TC-Seq, with minor modifications ([Fig. 6](#fig6){ref-type="fig"}). Only genomic alignments with at least 25 bp and a Phred score of 20 were accepted. Insertions were merged if they possessed genomic breakpoints within 5 bp of each other and occurred in the same orientation. Finally, reads that crossed the I-SceI site by more than 3 bp were excluded.

Analysis of rearrangements (TC-Seq) and insertions (IC-Seq) {#s24}
-----------------------------------------------------------

To characterize chromosomal rearrangements and insertions derived from distal regions ([Fig. 1, D--F](#fig1){ref-type="fig"}; and [Fig. 4, D--F](#fig4){ref-type="fig"}), the following portions of the genome were excluded: 50 or 20 kb surrounding the I-SceI site at *Myc^I^* (rearrangements or insertions, respectively), 2 kb surrounding cryptic I-SceI sites (consensus \[TCA\]\[AT\]GGGATA\[AC\]CAGG\[GCT\]\[TC\]\[ATC\]\[AG\]\[TAC\]), *RAG2* (likely representing retroviral integrations), 3 Mb at each centromere, and chromosome M (mitochondrial DNA).

To determine the enrichment at genic regions ([Figs. 1 D](#fig1){ref-type="fig"} and [4 D](#fig4){ref-type="fig"}), the portion of DNA from −2 kb of the most upstream transcription start site to the end of the last exon was considered as genic. For transcription analysis ([Figs. 1 E](#fig1){ref-type="fig"} and [4 E](#fig4){ref-type="fig"}), RNA-seq data ([@bib51]) were mapped with STAR aligner (v2.4.2a; default parameters; [@bib15]) using the mouse genome (mm10) and removing multiple alignments. Transcripts were quantified and annotated using cufflinks (v2.2.1; cuffdiff parameters: --upper-quartile-norm --dispersion-method per-condition; [@bib63]) and Ensembl annotation (release 80). Transcription groups were defined using the mclust R package: silent (0 FPKM), trace (0.000000522291--2.8443 FPKM), low (2.84555--11.9418 FPKM), medium (11.9476--47.115 FPKM), and high (47.1191--74.211 FPKM). To detect enrichment within ERFSs ([Figs. 1 F](#fig1){ref-type="fig"} and [4 F](#fig4){ref-type="fig"}), previously reported sites ([@bib5]) were lifted over from mouse genome mm9 to mm10 (UCSC LiftOver tool).

Detection of rearrangement breakpoint clusters (TC-Seq) {#s25}
-------------------------------------------------------

RAG1/2^core^-dependent breakpoint clusters were detected by a three-step process. First, RAG2^core^ and RAG2^−/−^ TC-Seq libraries were screened for local enrichment of rearrangement breakpoints to identify breakpoint hotspots (at least three breakpoints and a combined p-value of \<10^−8^; [@bib27]). To prevent potential sonication artifacts, hotspots were excluded if their sheared ends were either within less than 18 bp of each other or overlapped with simple repeat regions. Second, breakpoint hotspots were defined as RAG1/2^core^ dependent if they did not display any RAG2^−/−^ breakpoints or sheared ends within ±1-kb distance. Third, breakpoint clusters containing three or more events within up to 25 bp distance of each other were identified within each RAG1/2^core^ hotspot. Off-target clusters were manually filtered based on the location of recurrent breakpoints near CA motifs that were shared by at least three clusters (CACA, CACC, CACT, and CAGA). Simple CA-repeat regions were excluded. Putative cRSS sequences were manually detected and analyzed using Geneious ([@bib25]) and RSSsite (<http://www.itb.cnr.it/rss>; [@bib38]). Sequences of physiological RSSs were obtained from IMGT (<http://www.imgt.org/>) and published RSS datasets ([@bib11]). Annotation of V(D)J segments was based on Ensembl (release 80). Rearrangements crossing the I-SceI site were still allowed during the detection of breakpoint hotspots and clusters, but afterward manually removed from all sites in the final data.

Analysis of insertions in human tumors {#s26}
--------------------------------------

We designed a novel pipeline to search whole-genome sequences for insertions derived from *IG*/*TCR* loci. First, *IG*/*TCR* baits were generated that correspond to regions spanning 150 bp upstream and downstream from each physiological RSS cleavage site of human V and J segments (Ensembl, release 84). D segments were excluded, and repeat regions were masked. Second, whole-genome sequences from published human cancer datasets (Table S4; [@bib80]; [@bib22]; [@bib44]) were mapped with bwa mem (v0.7.12-r1039; default parameters) using the *IG*/*TCR* baits as references. Third, paired reads aligning to the baits were mapped against the human genome (hg38) using bwa mem (v0.7.12-r1039; default parameters). Only alignments with a Phred score of at least 20 were accepted. Finally, reads containing junctions (chimeric alignments) were filtered to yield insertions that were then manually verified using Geneious ([@bib25]). The analysis of publicly available human cancer datasets was classified as exempt activity by the Rockefeller University Institutional Review Board.

Deletion PCR assays {#s27}
-------------------

Genomic DNAs of TC-Seq (RAG2^core^ and RAG2^−/−^) and IC-Seq (RAG1/2 wild type) cultures were used for deletion PCR assays. Duplicates for RAG2^core^ and RAG2^−/−^ originated from cell cultures with modified conditions: control was infected with pMX-EGFP; cells were transferred onto irradiated S17 stroma cells after IL-7 washout on day 4 and depleted for 1.5 d. To detect small and rare deletion events, nested PCRs with a "poison" primer were performed ([@bib18]). For PCRI, 100 ng (Jκ1/2, Jκ4/5) or 200 ng (Vκ3-1) genomic DNA was amplified in 20-µl reactions with HotStarTaq polymerase (QIAGEN). For PCRII, 1 µl of PCRI was used as template. For deletions at Jκ1/2, primers p195/p256/p258 (PCRI) and p196/p257 (PCRII) were used with the following conditions: PCRI, 95°C for 15 min; 30× (95°C for 45 s, 63°C for 45 s, and 72°C for 25 s); and 72°C for 5 min; PCRII, 95°C for 15 min; 30× (95°C for 45 s, 63°C for 45 s, and 72°C for 10 s); and 72°C for 5 min (Table S5). For deletions at Jκ4/5, primers p199/p205/p255 (PCRI) and p200/p206 (PCRII) were used with the same cycling conditions as for Jκ1/2 (Table S5). For deletions at Vκ3-1, primers p243/p244/p245 (PCRI) and p207/p210 (PCRII) were used with the following conditions: PCRI, 95°C for 15 min; 30× (95°C for 45 s, 63°C for 45 s, and 72°C for 50 s); and 72°C for 5 min; PCRII, 95°C for 15 min; 30× (95°C for 45 s, 63°C for 45 s, and 72°C for 20 s); and 72°C for 5 min (Table S5). PCRII products were separated on 2% agarose gels stained with ethidium bromide. Fragments shorter than the expected size from the germline locus (Jκ1/2: \<592 bp, Jκ4/5: \<575 bp, and Vκ3-1: \<635 bp) were extracted (MACHEREY-NAGEL) and sequenced (Genewiz). Deletion products were confirmed using Geneious ([@bib25]).

V(D)J PCR assays {#s28}
----------------

Genomic DNAs of TC-Seq (RAG2^core^ and RAG2^−/−^) cultures were used for V(D)J PCR assays. For RAG2^full^, cells were cultured as for TC-Seq but infected with pMX-I-SceI-P2A-RAG2^full^-EGFP. Duplicates originated from cell cultures with modified conditions: control was infected with pMX-EGFP; all cells were transferred onto irradiated S17 stroma cells after IL-7 washout on day 4 and depleted for 1.5 d. Semiquantitative V(D)J PCRs were performed as previously described ([@bib58]; [@bib16]) with modifications: 100, 50, or 25 ng of template DNA was amplified in 20-µl reactions with HotStarTaq polymerase (QIAGEN). For V(D)J PCRs, primers p58/p96 (Dh-Jh PCR), p96/p98 (VhQ52-DJh PCR), and p305/p306 (Vκ-Jκ PCR) were used with the following conditions: 95°C for 15 min; 32× (95°C for 45 s, 62°C for 45 s, and 72°C for 2 min); and 72°C for 5 min (Table S5). For control PCRs (*Myc^I^*) primers p113/p114 were used with the following conditions: 95°C for 15 min; 30× (95°C for 45 s, 58°C for 45 s, and 72°C for 20 s); and 72°C for 5 min (Table S5). PCR products were separated on 1.5% agarose gels stained with ethidium bromide.

Accession numbers {#s29}
-----------------

The TC-Seq and IC-Seq sequencing data generated in this study can be accessed from the SRA database (SRP077983).

Online supplemental material {#s30}
----------------------------

Fig. S1 describes the RAG2-expressing retroviruses used in this study. Fig. S2 characterizes RAG1/2^core^-dependent rearrangement breakpoint clusters at cRSSs. Fig. S3 shows the sequences of inserted *IG*/*TCR* fragments identified in human cancers. Table S1 lists features of RAG1/2^core^-dependent breakpoint clusters detected by TC-Seq. Table S2 summarizes the RIC score analysis of identified cRSSs. Table S3 displays features of *Igκ* insertions detected by TC-Seq and IC-Seq. Table S4 summarizes the insertion analysis of human cancers. Table S5 lists primers used in this study. Tables S1--S5 are included as Excel files.
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